Pharmaceutical Technology releases the fifth notice of early redemption for PharMstone Convertible Bonds.

Nanjing Pharmaceutical Technology Co., Ltd. issued the fifth pre-redemption notice for the redemption of pharmaceutical stone convertible bonds. Due to the company's stock closing price being at least 130% of the current conversion price of the pharmaceutical stone convertible bonds for at least fifteen trading days out of the last thirty consecutive trading days, triggering the conditional redemption clause. The redemption price is 100.62 yuan per bond, the redemption registration date is September 17, 2025, and the redemption date is September 18. This redemption is for all outstanding bonds, and after the redemption is completed, the pharmaceutical stone convertible bonds will be delisted from the Shenzhen Stock Exchange.